O. Milaş

MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients

P. Matusz, F. Bob, S. Velciov, 2019, Endocrine research.

Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus

P. Matusz, F. Bob, S. Velciov, 2017, Journal of Investigative Medicine.

Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus.

F. Bob, S. Velciov, F. Gădălean, 2011, Diabetes research and clinical practice.

Proximal Tubule Dysfunction Is Dissociated from Endothelial Dysfunction in Normoalbuminuric Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

F. Bob, S. Velciov, F. Gădălean, 2010, Nephron Clinical Practice.

Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients.

P. Matusz, F. Bob, S. Velciov, 2019, Biomarkers in medicine.

Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients.

P. Matusz, F. Bob, S. Velciov, 2019, Journal of diabetes and its complications.

Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus.

A. Zamfir, F. Bob, S. Velciov, 2015, International journal of clinical and experimental medicine.

Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

F. Bob, S. Velciov, F. Gădălean, 2014, PloS one.

Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus

P. Matusz, F. Bob, S. Velciov, 2017, Diabetology & Metabolic Syndrome.